ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Apr 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
May 2026
Nuclear Technology
March 2026
Fusion Science and Technology
Latest News
Chernobyl at 40 years: Looking back at Nuclear News
Sunday, April 26, at 1:23 a.m. local time will mark 40 years since the most severe nuclear accident in history: the meltdown of Unit 4 at the Chernobyl nuclear power plant in Ukraine, then part of the Soviet Union.
In the ensuing four decades, countless books, documentaries, articles, and conference sessions have examined Chernobyl’s history and impact from various angles. There is a similar abundance of outlooks in the archives of Nuclear News, where hundreds of scientists, advocates, critics, and politicians have shared their thoughts on Chernobyl over the years. Today, we will take a look at some highlights from the pages of NN to see how the story of Chernobyl evolved over the decades.
The Nuclear Energy Institute is the policy organization of the nuclear technologies industry, based in Washington, D.C.
NEI's mission is to promote the use and growth of nuclear energy through efficient operations and effective policy.
NEI accomplishes this by providing a unified industry voice before Congress, the executive branch, state, and local legislatures, and federal regulators, as well as international organizations and venues, on key policy issues.
NEI's members include companies that own or operate nuclear power plants, reactor designers and advanced technology companies, architect and engineering firms, fuel suppliers and service companies, consulting services and manufacturing companies, companies involved in nuclear medicine and nuclear industrial applications, radionuclide and radiopharmaceutical companies, universities and research laboratories, law firms, labor unions, and international electric utilities.